DPhil MSc MD(Hons) BSc BA
Professor of Health Economics, Department of Health Economics, Centre for Public Health, Medical University of Vienna, Austria
Judit Simon is Professor of Health Economics and Head of the Department of Health Economics, Centre for Public Health at the Medical University of Vienna. She has previously held appointments at the University College London (UCL), the London School of Economics and Political Science (LSE) and the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford where she remains a Research Associate. She is Visiting Professor of Cognitive Health Economics at the Department of Psychiatry, University of Oxford and Senior Research Fellow at the Oxford Health NHS Foundation Trust.
Professor Simon holds a DPhil in Public Health from the University of Oxford; an MSc in Health Economics from the University of York; and a Doctor of Medicine (Hons), a BSc in Economics and a BA in Medical Translation from the University of Szeged.
Over the years, Professor Simon has led numerous applied economic evaluation and outcome research projects in the areas of mental health, diabetes and perinatology; taught at various undergraduate, graduate and professional courses; and acted as reviewer or contributor to several international organisations and journals.
Her primary research interests include the delivery of cost-effective interventions for people with mental health disorders; the operationalisation of the capabilities approach for outcome measurement in mental health research; cost-effective clinical guideline development; broader system-level evaluation and international comparison of health services; and comparative health systems and health care rationing research with a specific attention to transition economy countries.
Psychoeducation and online mood tracking for patients with bipolar disorder: A randomised controlled trial.
Bilderbeck AC. et al, (2016), J Affect Disord, 205, 245 - 251
EQ-5D in Central and Eastern Europe: 2000–2015
Simon J. et al, (2016), Quality of Life Research
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
Barnes TR. et al, (2016), Health Technol Assess, 20, 1 - 46
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.
Geddes JR. et al, (2016), Lancet Psychiatry, 3, 31 - 39
A randomised controlled trial of positive memory training for the treatment of depression within schizophrenia
Steel C. et al, (2015), BMC Psychiatry, 15